If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

Share Price is delayed by 15 minutes
Get Live Data
335.00    -5.00 (-1.47%)
Bid:
320.00
Ask:
350.00
Spread: 30.00 (9.375%)
Market Cap: £58.39m
TRD Live PriceLast checked at - London Stock Exchange

Intraday Triad Share Chart

Director/PDMR Shareholding

Today 15:00

RNS Number : 8370K
Triad Group Plc
02 July 2026
 

Legal Entity Identifier (LEI) No. 213800MDNBFVEQEN1G84

Triad Group Plc

("Triad" or "the Company")

Director Dealings

The Company announces that it has been informed that, on 1 July 2026, Tim Eckes (Client Services Director) has in order to effect a "Bed and ISA" transaction, sold 1,667 ordinary shares of £0.01 each ("Ordinary Shares") at a price of 320.00 pence per Ordinary Share and then repurchased into his Individual Savings Account (ISA), the same number of 1,667 Ordinary Shares at an average price of 322.14 pence per Ordinary Share.

Following the completion of these transactions his ultimate beneficial ownership is unchanged and remains at 147,180 Ordinary Shares in total, representing approximately 0.84% of the Company's total voting rights.

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the transactions.

1.

Details of PDMR / person closely associated with them

a)

Name

Tim Eckes

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Triad Group Plc

b)

LEI

213800MDNBFVEQEN1G84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of £0.01 each

 

ISIN: GB0009035741

b)

Nature of the transaction

On market sale of Ordinary Shares and immediate repurchase by way of Bed and ISA arrangement

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£3.2000 (sale)

£3.2200 (purchase)

£3.3400 (purchase)

1,667

1,648

19

d)

Aggregated information

-Aggregated sale

-Aggregated purchase

 

1,667 - average price of £3.2000

1,667 - average price of £3.2214

e)

Date of the transaction

1 July 2026

f)

Place of the transaction

LONDON STOCK EXCHANGE XLON

 

For further information, please contact:

Triad Group Plc

James McDonald

Finance Director and Company Secretary

01908 278 450

 

Zeus Capital Limited

Darshan Patel

Tel: 020 7614 5900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUUVARNUUBRAR
Date   Source Headline
17th Feb 20212:01 pmRNSPrice Monitoring Extension
29th Jan 20214:00 pmRNSTotal Voting Rights
27th Jan 202111:05 amRNSSecond Price Monitoring Extn
27th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 20212:00 pmRNSTrading Statement
13th Jan 20214:00 pmRNSDirector/PDMR Shareholding
8th Jan 202111:06 amRNSSecond Price Monitoring Extn
8th Jan 202111:01 amRNSPrice Monitoring Extension
7th Jan 20214:00 pmRNSStatement re Share Price Movement
7th Jan 202111:05 amRNSSecond Price Monitoring Extn
7th Jan 202111:00 amRNSPrice Monitoring Extension
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
5th Jan 20214:40 pmRNSSecond Price Monitoring Extn
5th Jan 20214:35 pmRNSPrice Monitoring Extension
5th Jan 20212:05 pmRNSSecond Price Monitoring Extn
5th Jan 20212:00 pmRNSPrice Monitoring Extension
5th Jan 202111:00 amRNSPrice Monitoring Extension
5th Jan 20219:06 amRNSSecond Price Monitoring Extn
5th Jan 20219:00 amRNSPrice Monitoring Extension
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
27th Nov 20209:05 amRNSSecond Price Monitoring Extn
27th Nov 20209:00 amRNSPrice Monitoring Extension
27th Nov 20207:00 amRNSHalf-year Report
24th Sep 20204:30 pmRNSResult of AGM
14th Sep 20207:00 amRNSBlock listing Interim Review
9th Sep 20204:00 pmRNSTotal Voting Rights
28th Aug 20202:00 pmRNSNotice of AGM
18th Jun 20207:00 amRNSFinal Results
17th Jun 202011:16 amRNSDirectorate Change
16th Mar 202010:24 amRNSBlock listing Interim Review
2nd Mar 20204:00 pmRNSChange of Company Secretary
2nd Mar 20201:16 pmRNSTotal Voting Rights
20th Feb 20203:00 pmRNSPCA Share Purchase
3rd Feb 202012:20 pmRNSDirector/PCA Dealings
9th Jan 20207:00 amRNSFramework Partnership with Stratis Group Ltd
20th Dec 20197:00 amRNSDirectorate Change
20th Dec 20197:00 amRNSHalf-year Report
6th Dec 20193:00 pmRNSTotal Voting Rights
23rd Sep 20192:34 pmRNSDirectorate Resignation
13th Sep 20193:09 pmRNSBlock listing Interim Review
14th Aug 20192:47 pmRNSResult of AGM
5th Aug 20192:11 pmRNSDirectorate Resignation
18th Jul 201911:39 amRNSNotice of AGM
10th Jun 20199:45 amRNSCorrection to dividend payment date
10th Jun 20197:00 amRNSFinal Results
14th Mar 20194:16 pmRNSBlock listing Interim Review
1st Mar 20193:25 pmRNSStatement re Recent High Court Hearing
1st Feb 20191:17 pmRNSDirector/PDMR Shareholding and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.